Author:
Kahl Brad S.,Bartlett Nancy L.,Leonard John P.,Chen Ling,Ganjoo Kristen,Williams Michael E.,Czuczman Myron S.,Robinson K. Sue,Joyce Robin,van der Jagt Richard H.,Cheson Bruce D.
Reference29 articles.
1. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma;Marcus;Blood.,2005
2. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddemann;Blood.,2005
3. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study;Herold;J Clin Oncol.,2007
4. Update of the FL2000 randomized trial combining rituximab to CHVP-interferon in follicular lymphoma patients;Foussard;J Clin Oncol.,2006
5. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin's Lymphomas. Version 3.2008. 04/10/08. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf Accessed January 13, 2009.
Cited by
204 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献